Literature DB >> 31961822

Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.

Richard O Francis1, Angelo D'Alessandro2, Andrew Eisenberger3, Mark Soffing4, Randy Yeh4, Esther Coronel4, Arif Sheikh5, Francesca Rapido6, Francesca La Carpia1, Julie A Reisz2, Sarah Gehrke2, Travis Nemkov2, Tiffany Thomas1, Joseph Schwartz1, Chaitanya Divgi4, Debra Kessler7, Beth H Shaz7, Yelena Ginzburg8, James C Zimring9, Steven L Spitalnik1, Eldad A Hod1.   

Abstract

BACKGROUNDGlucose-6-phosphate dehydrogenase (G6PD) deficiency decreases the ability of red blood cells (RBCs) to withstand oxidative stress. Refrigerated storage of RBCs induces oxidative stress. We hypothesized that G6PD-deficient donor RBCs would have inferior storage quality for transfusion as compared with G6PD-normal RBCs.METHODSMale volunteers were screened for G6PD deficiency; 27 control and 10 G6PD-deficient volunteers each donated 1 RBC unit. After 42 days of refrigerated storage, autologous 51-chromium 24-hour posttransfusion RBC recovery (PTR) studies were performed. Metabolomics analyses of these RBC units were also performed.RESULTSThe mean 24-hour PTR for G6PD-deficient subjects was 78.5% ± 8.4% (mean ± SD), which was significantly lower than that for G6PD-normal RBCs (85.3% ± 3.2%; P = 0.0009). None of the G6PD-normal volunteers (0/27) and 3 G6PD-deficient volunteers (3/10) had PTR results below 75%, a key FDA acceptability criterion for stored donor RBCs. As expected, fresh G6PD-deficient RBCs demonstrated defects in the oxidative phase of the pentose phosphate pathway. During refrigerated storage, G6PD-deficient RBCs demonstrated increased glycolysis, impaired glutathione homeostasis, and increased purine oxidation, as compared with G6PD-normal RBCs. In addition, there were significant correlations between PTR and specific metabolites in these pathways.CONCLUSIONBased on current FDA criteria, RBCs from G6PD-deficient donors would not meet the requirements for storage quality. Metabolomics assessment identified markers of PTR and G6PD deficiency (e.g., pyruvate/lactate ratios), along with potential compensatory pathways that could be leveraged to ameliorate the metabolic needs of G6PD-deficient RBCs.TRIAL REGISTRATIONClinicalTrials.gov NCT04081272.FUNDINGThe Harold Amos Medical Faculty Development Program, Robert Wood Johnson Foundation grant 71590, the National Blood Foundation, NIH grant UL1 TR000040, the Webb-Waring Early Career Award 2017 by the Boettcher Foundation, and National Heart, Lung, and Blood Institute grants R01HL14644 and R01HL148151.

Entities:  

Keywords:  Hematology; Monogenic diseases

Year:  2020        PMID: 31961822      PMCID: PMC7191001          DOI: 10.1172/JCI133530

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  Aggregation of blood platelets by adrenaline and its uptake.

Authors:  W Barthel; F Markwardt
Journal:  Biochem Pharmacol       Date:  1975-10-15       Impact factor: 5.858

2.  Active transport of GSSG from reconstituted erythrocyte ghosts.

Authors:  J Prchal; S K Srivastava; E Beutler
Journal:  Blood       Date:  1975-07       Impact factor: 22.113

3.  The red cell chromium elution rate in patients with some hematologic diseases.

Authors:  M J CLINE; N I BERLIN
Journal:  Blood       Date:  1963-01       Impact factor: 22.113

4.  Intradonor reproducibility and changes in hemolytic variables during red blood cell storage: results of recall phase of the REDS-III RBC-Omics study.

Authors:  Marion C Lanteri; Tamir Kanias; Sheila Keating; Mars Stone; Yuelong Guo; Grier P Page; Donald J Brambilla; Stacy M Endres-Dighe; Alan E Mast; Walter Bialkowski; Pam D'Andrea; Ritchard G Cable; Bryan R Spencer; Darrell J Triulzi; Edward L Murphy; Steven Kleinman; Mark T Gladwin; Michael P Busch
Journal:  Transfusion       Date:  2018-11-08       Impact factor: 3.157

5.  Metabolomics of ADSOL (AS-1) red blood cell storage.

Authors:  John D Roback; Cassandra D Josephson; Edmund K Waller; James L Newman; Sulaiman Karatela; Karan Uppal; Dean P Jones; James C Zimring; Larry J Dumont
Journal:  Transfus Med Rev       Date:  2014-02-05

6.  Personalised Transfusion Medicine.

Authors:  Angelo D'Alessandro; Giancarlo Liumbruno
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

7.  Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease.

Authors:  Payal C Desai; Allison M Deal; Emily R Pfaff; Bahjat Qaqish; Leyna M Hebden; Yara A Park; Kenneth I Ataga
Journal:  Am J Hematol       Date:  2015-05-28       Impact factor: 10.047

Review 8.  Inborn defects in the antioxidant systems of human red blood cells.

Authors:  Rob van Zwieten; Arthur J Verhoeven; Dirk Roos
Journal:  Free Radic Biol Med       Date:  2013-12-06       Impact factor: 7.376

9.  Heterogeneity of blood processing and storage additives in different centers impacts stored red blood cell metabolism as much as storage time: lessons from REDS-III-Omics.

Authors:  Angelo D'Alessandro; Rachel Culp-Hill; Julie A Reisz; Mikayla Anderson; Xiaoyun Fu; Travis Nemkov; Sarah Gehrke; Connie Zheng; Tamir Kanias; Yuelong Guo; Grier Page; Mark T Gladwin; Steve Kleinman; Marion Lanteri; Mars Stone; Michael Busch; James C Zimring
Journal:  Transfusion       Date:  2018-10-24       Impact factor: 3.157

10.  Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage.

Authors:  Travis Nemkov; Kaiqi Sun; Julie A Reisz; Anren Song; Tatsuro Yoshida; Andrew Dunham; Matthew J Wither; Richard O Francis; Robert C Roach; Monika Dzieciatkowska; Stephen C Rogers; Allan Doctor; Anastasios Kriebardis; Marianna Antonelou; Issidora Papassideri; Carolyn T Young; Tiffany A Thomas; Kirk C Hansen; Steven L Spitalnik; Yang Xia; James C Zimring; Eldad A Hod; Angelo D'Alessandro
Journal:  Haematologica       Date:  2017-10-27       Impact factor: 9.941

View more
  25 in total

1.  Diagnosis and clinical management of enzymopathies.

Authors:  Lucio Luzzatto
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.

Authors:  Adriana A Garcia; Ana Koperniku; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Trends Pharmacol Sci       Date:  2021-08-10       Impact factor: 17.638

3.  Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects.

Authors:  Alkmini T Anastasiadi; Vassilis L Tzounakas; Monika Dzieciatkowska; Vasiliki-Zoi Arvaniti; Effie G Papageorgiou; Issidora S Papassideri; Konstantinos Stamoulis; Angelo D'Alessandro; Anastasios G Kriebardis; Marianna H Antonelou
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

4.  Reprogramming of red blood cell metabolism in Zika virus-infected donors.

Authors:  Alexis Catala; Mars Stone; Michael P Busch; Angelo D'Alessandro
Journal:  Transfusion       Date:  2022-03-14       Impact factor: 3.337

5.  Stored RBC metabolism as a function of caffeine levels.

Authors:  Angelo D'Alessandro; Xiaoyun Fu; Julie A Reisz; Tamir Kanias; Grier P Page; Mars Stone; Steve Kleinman; James C Zimring; Michael Busch
Journal:  Transfusion       Date:  2020-05-11       Impact factor: 3.157

6.  Quantifying dynamic range in red blood cell energetics: Evidence of progressive energy failure during storage.

Authors:  Stephen C Rogers; Xia Ge; Mary Brummet; Xue Lin; David D Timm; Andre d'Avignon; Joel R Garbow; Jeff Kao; Jaya Prakash; Aaron Issaian; Elan Z Eisenmesser; Julie A Reisz; Angelo D'Alessandro; Allan Doctor
Journal:  Transfusion       Date:  2021-04-08       Impact factor: 3.157

7.  Red cell proteasome modulation by storage, redox metabolism and transfusion.

Authors:  Vassilis L Tzounakas; Monika Dzieciatkowska; Alkmini T Anastasiadi; Dimitrios G Karadimas; Athina Vergaki; Panagiotis Siourounis; Konstantinos Stamoulis; Issidora S Papassideri; Anastasios G Kriebardis; Angelo D'Alessandro; Marianna H Antonelou
Journal:  Blood Transfus       Date:  2020-11-27       Impact factor: 3.443

8.  Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.

Authors:  Marianne E Yee; Richard O Francis; Naomi L C Luban; Kirk A Easley; Christopher M Lough; John D Roback; Cassandra D Josephson; Ross M Fasano
Journal:  Transfusion       Date:  2022-01-19       Impact factor: 3.157

9.  Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality.

Authors:  Tiffany Thomas; Francesca Cendali; Xiaoyun Fu; Fabia Gamboni; Evan J Morrison; Jonathan Beirne; Travis Nemkov; Marianna H Antonelou; Anastasios Kriebardis; Ian Welsby; Ariel Hay; Karolina H Dziewulska; Michael P Busch; Steven Kleinman; Paul W Buehler; Steven L Spitalnik; James C Zimring; Angelo D'Alessandro
Journal:  Transfusion       Date:  2021-04-26       Impact factor: 3.337

Review 10.  Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.

Authors:  Dito Anurogo; Nova Yuli Prasetyo Budi; Mai-Huong Thi Ngo; Yen-Hua Huang; Jeanne Adiwinata Pawitan
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.